Lysine deacetylases or histone deacetylases (HDACs) remove acetylation markers from numerous cellular proteins, thereby regulating their function and activity.R ecently established peptidep robes containing the HDAC-trapping amino acid aaminosuberic acid w-hydroxamate (AsuHd) have been used to investigate the compositions of HDAC complexes in as ite-specific manner.H ere we report the new HDAC-trapping amino acid 2-amino-8-[(2-aminophenyl)amino]-8-oxooctanoic acid (AsuApa) and the utility of AsuApa-containing probesf or HDAC complex profiling on ap roteome-wide scale. Unlike AsuHd-containing probes, AsuApae nriched only HDACs 1, 2, and 3e fficientlya nd was the mostp otent probe tested for capturing the last of these.T hese findings indicate that the inherents pecificity of reporteds mall-molecule pimelic diphenylamide HDAC inhibitors is preserved in AsuApa and that this HDAC-trapping amino acid represents ap otent tool for investigating class IHDAC complexes.
Lysine acetylation is af requent andr eversiblep osttranslational modification (PTM) of eukaryotic proteomes. [1] This PTM was first discovered on histones, where it plays ac entral role in regulating transcription and chromatin condensation states. More recenti nvestigationsh ave shown that lysine acetylation also features in am ultitude of non-histone proteins and represents one of the most abundant PTMs in nature. [2] Lysine acetylation is installed through the action of lysine acetyltransferases (KATs)a nd removed through that of lysine deacetylases or histonedeacetylases (HDACs, Scheme 1A).
The Zn 2 + -dependent HDACs( hereafter referredt os imply as HDACs) form am ajor family among the deacetylases and cleave the Ne-amides by direct hydrolysis of the amide bond. [3] This mechanism is distinct from that of NAD + -dependent sirtuins, which form af urtherm ajor deacetylase family. [4] HDACs can be furthers ubdivided into classes I, IIa, IIb, and IV by homologyt oy east HDACs Rpd3 and HD1.
Class IH DACs consist of HDACs1 ,2 ,3 ,a nd 8. With the exceptiono fH DAC8t hese enzymes are confined to the nucleus, where they regulate transcription through deacetylation of histones anda lso of non-histone proteins. [5] HDACs of class II shuttle between nucleus and cytoplasm and are furtherd ivided into the poorly active class IIa enzymes (HDACs 4, 5, 7, and 9) and the active class IIb HDACs (HDAC6 and HDAC10). [5] Whereas HDAC6i sa na bundantl ysine deacetylase with many cytosolic substrates, HDAC10 was reported to possess polyamine deacetylase activity. [6] Finally,l ittle informationi sa vailable about the physiological role of HDAC11, the only knownm ember of the class IV HDACs. However,r ecent publications have shown that this enzymei sc apable of removing long-chain N-acyl modifications from lysine residues. [7] HDACs represent promising drugt argets,d ue to their regulatory function in chromatin,s ignaling, and metabolism, and severalH DAC inhibitors, including the FDA-approved suberoylanilideh ydroxamic acid (SAHA), have been developed (Scheme 1A). [3, 5] However,H DACs are known to form multiprotein complexes,a nd many components of HDAC complexes potentially modulate activity and specificity of the imbedded deacetylases,t hereby complicating biochemical research. [8] Strategies for profiling HDAC complexes in as ubstrate-sitedependent manner have been established. [9] HDAC-trapping amino acids, such as AsuHd, the hydroxamic acid derivative of 2-aminosuberic acid, were developedf or replacing acetyllysine residues in peptide probes derived from known acetylation sites (Scheme 1B). [10] When combinedw ithM S-based methods of interactome profiling,t hese peptide-based probes can uncover the compositions of HDAC complexes in their associated peptide substrate contexts. However,H DAC-trapping amino acids likely possess an inherent selectivity for HDACs themselves, so a broad set of HDAC-trapping amino acids is desirable for optimal targeting of individual HDAC complexes.
Here we report the synthesis and characterization of the HDAC-trapping amino acid dl-2-amino-8-[(2-aminophenyl)amino]-8-oxooctanoic acid (AsuApa), designed on the basis of the HDAC inhibitorM S-275( Scheme 1). [11] AsuApa has previously been installed into ac yclic peptideH DAC inhibitorb ya no nresin strategy. [12] We have followed ad ifferent approach, by synthesizing ap rotectedA suApab uildingb lock for solid-phase peptides ynthesis( SPPS). This appeared more flexible for the design of peptide-based HDAC probes. The 2-aminophenylamide-containing dl-AsuApa was synthesized from dl-2-aminosuberic acid (1,S cheme2A). The a-aminoa nd -carboxylic acid groups were first protected by complexation with 9-borabicyclo[3.3.1]nonane( 9-BBN)t of orm 2,f ollowed by acyl chloride formation at the side chain with thionyl chloride. [13] The freshly formed acyl chloride was coupled with N-Boc-1,2-phenylenediamine,r esulting in 9-BBN-protected AsuApa(Boc) (3). Treatment of 3 with ethylenediamine to remove9 -BBN resulted in 4,and subsequentinstallation of the fluorenylmethoxycarbonyl (Fmoc) protecting group with Fmoc N-hydroxysuccinimide ester (Fmoc-OSu) furnished the Fmoc-AsuApa(Boc)-OH (5) buildingb lock (Scheme 2A).
With Fmoc-AsuApa(Boc)-OH to hand we set out to synthesize the corresponding AsuApa-containingp eptidep robe mini-AsuApa (P3,S cheme2B). Previous reports have shown that probesc ontaining a-aminosuberic acid w-hydroxamate (AsuHd) efficiently recruit HDAC complexes of class Ia nd IIb from lysates of mammalianc ells. The general design of this mini-AsuHdp robe (P2)c onsisted of the AsuHd building block flankedb yg lyciner esiduesa nd aC -terminal poly(ethylene glycol) (PEG) and cysteine extension used for immobilization on as olid support (Scheme2B). Mini-Lys probe P1,w ith AsuHd replaced by al ysine residue, did not recruit HDACsa nd served as control. Mini-AsuApa (P3)w as designed in the same way with AsuApa as the central amino acid. The peptide was assembled on the solids upport by standard SPPS methods, Fmoc-AsuApa(Boc)-OHb eing fully compatible with these conditions. After synthesis the mini-AsuApa peptidew as purified by HPLC and immobilized on iodoacetyl-modified agarose to form the mini-AsuApa probe. Mini-AsuHd and mini-Lys peptides and probeswere synthesized as reported previously.
We analyzed the ability of mini-AsuApa, in comparison with mini-AsuHd and mini-Lys probes, to recruit endogenousH DAC complexes from cellular lysates. Native lysate of HeLa cells was used as input at af ixed concentration of 1mgmL À1 (200 mg total protein). Upon pull-down, the resins were washed,a nd proteins recruited to either of these probes weree luted,r esolved on SDS-PAGE, anda nalyzed by westernb lot. The blots were probed with antibodies againsta ll HDACs of class Ia nd class IIb and against HDAC4a sarepresentative member of the class IIa enzymes.C onsistent with previous reports, we observed that all endogenous HDACso fc lasses Ia nd IIb bound mini-AsuHd, but not mini-Lys (Figure 1 ). Recruitment of HDAC4 to mini-AsuHd was weak and barely detectable. Mini-AsuApa showedadifferent binding pattern from mini-AsuHd and did not recruit class IIb enzymes,H DAC8, or HDAC4. However,e fficient binding of the other class Ie nzymes-HDAC1, HDAC2, and HDAC3-was observed (Figure 1 ). This bindingp attern is reminiscent of the reported specificity of benzamide HDAC inhibitor MS-275 (Entinostat), which inhibits HDAC1 and HDAC3 strongly,b ut not HDAC8 and class II HDACs. The poor recruitment of HDAC4t om ini-AsuApa also fits the specificity profile of MS-275( Figure 1 ). [14] To obtain quantitative information about the HDAC binding properties of mini-AsuApa and the compositions of recruited HDAC complexes, we performed ac hemical proteomics profiling of mini-AsuApa, in comparison with mini-AsuHd and mini-Lys, by label-free LC-MS/MS analysis. Pull-downs from HeLa whole cell lysates were performed as before,b ut eluted proteins were alkylated at cysteiner esidues,s ubjected to tryptic digestion, and identified and relativelyq uantified by LC-MS/MS with use of the MaxLFQ algorithm of the MaxQuant software package (Tables S1-S3 in the Supporting Information). [15] Proteins enriched on mini-AsuHd and mini-AsuApa, in comparison with mini-Lys, from three biological replicates were visualized by use of volcano plots (Figure 2A and B) . The log 2 -fold enrichment ratios of mini-AsuHd and mini-AsuApa versusm ini-Lys were plotted against the negative log 10 p value, showingsignificantly enrichedp roteins in the upper right-hand sections of the volcano plots. Statistical analysisw as performedw ith proteins identified and quantified in all three biological replicates-including HDAC1, HDAC2, HDAC3, and HDAC6-that fulfilled these criteria.C onsistently with previousr eports we observedt hat all of the above HDACs weres ignificantly enriched on mini-AsuHd in comparison with mini-Lys. [10] HDAC6 shows the strongest enrichment of all detected proteins. Furthermore, proteins of known complexes of HDAC1a nd HDAC2, including RBBP7 and p66 of NuRD andS in3A complexes, as well as KDM1Aa nd RCOR3 of the CoREST complex, were enriched on mini-AsuHd. [16] Components of the latter complex showed stronger enrichmentt han proteins of the former.H DAC3w as also enriched on mini-AsuHd,b ut not to the same extent as HDACs 1, 2, and 6. This pattern is also reflected in the enrichmento fc omponentso ft he NCoR/SMRT complex, such as NCOR1, NCOR2, and TBL1X, whichc ontains HDAC3asc atalytic subunit. [17] The volcano plot of the interactome of mini-AsuApav ersus mini-Lys showed ad ifferent binding profile from that of mini-AsuHd ( Figure 2B ): HDAC6 was only marginally enriched on mini-AsuApa;t his is consistentw itht he western blot analysis (Figure 1 ). Am ajor fractiono fp roteins enriched on mini-AsuApa belongs to the NuRD/Sin3A and CoREST complexes; this further supports the notion that mini-AsuApa servesa sa probe for HDACs 1a nd 2. Furthermore, HDAC3 and proteins of the corresponding NCoR/SMRT complex bound strongly to mini-AsuApa, and this interaction appeared more pronounced than the corresponding enrichment on mini-AsuHd. NCoR/ SMRT proteins TBL1X and NCOR1, for example, rank among the mosth ighly enriched proteins identified with mini-AsuApa. Plotting of the enrichment of proteins on mini-AsuApa against mini-AsuHd (Figure2C) allowed am ore direct comparison of the binding properties of both probes. Proteinse nriched on mini-AsuApa are located in the upper right-hand section of the plot, whereas proteins enriched on mini-AsuHd are found in the upper left-hand section. Proteins binding evenly to both probesa re confined to the center ( Figure 2C ). HDAC6i sl ocated in the upper left-hand segment of the plot, thus confirming that mini-AsuApa is not capable of efficient HDAC6 recruitment. Proteins of the NuRD, Sin3A, and CoREST complexesi ncluding HDACs 1a nd 2a re located in the center,t hus indicating comparable recruitment to mini-AsuHd and mini-AsuApa. Proteinso ft he NCoR/SMRTc omplex are primarily located in the upper right-hand section of the plot, thuss howing that mini-AsuApa is as uperiorp robe recruiting HDAC3 and complexes imbedding HDAC3.
Collectively,t he interactome studies and western blot analysis showed that AsuApa serves as ap robe for complexes of HDACs1 ,2 ,a nd 3w hen imbedded in ap eptides caffold. No significant interactions with other HDACsw ere observed. Furthermore, mini-AsuApa was more potent than mini-AsuHd in enriching HDAC3 and NCOR/SMRT complex proteins. The binding properties of mini-AsuApa differ from the inhibitory properties of the parent MS-275, which inhibits both HDAC1a nd HDAC3w ith similar efficiency. [14] Furthermore, activity-based probesd erived from MS-275 interacted only weakly with en-dogenousH DACs of HeLa nuclei lysates. [18] The o-phenylenediamine moiety is linked to an aliphatic carboxylic acid in AsuApa, unlike in the MS-275 scaffold, in which this moiety is coupled to an aromatic benzoica cid derivative. This observation promptst he conclusion that the aliphatic side chain of AsuApa is important for HDAC3s electivity;t his is also supported by pimelic diphenylamide inhibitor 106, which displays HDAC binding properties similart ot hose of mini-AsuApa. [19] Furthermore, an activity-based probe derived from compound 106 was shown to interactw ith HDAC3 most efficiently, thus indicating that the inherent selectivity of this small-molecule compound is also preserved in mini-AsuApa. [19] Peptide-based probesr epresent important tools for investigating the compositions of HDAC complexes in as ubstratesite-dependent manner. HDAC-trapping amino acids commonly possess an inherent HDAC specificity,s ot he establishment of as et of such amino acids is important for covering all 11 mammalian HDACs. Thei nitially introduced AsuHd binds all HDACso fc lass Ia nd IIb. [10] Further reportedH DAC-binding amino acids include Ne-acetyl-Ne-hydroxy-l-lysine {Lys[N(O-H)Ac]}, which interacts with HDACs 1, 2, and 6, and the recently reported trifluoromethyl ketone amino acid Atona, which targets HDACs of class IIa. [20] With AsuApa, we now introduce a new HDAC-trapping amino acid that allows HDACs 1a nd 2 and, in particular, HDAC3a nd its binding proteinst ob ea ddressed. The abundance of HDACsa nd HDAC complexes can vary strongly between cells, thus imposing am ajor obstacle to targeting of low-abundance endogenous deacetylases. The enrichment of HDACso np eptide-based probes is determined by affinity and abundanceo ft he enzymes,a nd low-abundance HDACsm ight be driven off pan-specific probes by high-abundance HDACs. Use of HDAC-specific trapping residues in peptide probes seems an attractive strategy for addressing this problem.T his broad set of HDAC-trapping amino acids now availablec an be used to investigate the impact of acetylation sites on the composition of the HDAC complex by combining HDAC-trapping amino acids with peptidec ontextsd erived from acetylation sites in amix-and-match type of fashion.
Experimental Section
Asu-BBN (2): dl-2-Aminosuberic acid (1,1 .89 g, 10.0 mmol, 1equiv) was suspended in anhydrous MeOH (60 mL) and heated at reflux under nitrogen. Subsequently,9 -BBN (0.5 m in THF,2 2mL, 11.0 mmol, 1.1 equiv) was added dropwise, and the mixture was heated until the suspension had cleared (approximately 2h). The solvent was removed under reduced pressure, and the colorless, viscous residue was purified by preparative HPLC. The desired product 2 was obtained as aw hite powder (2.81 g, 9.09 mmol, 91 %).
AsuApa(Boc)-BBN (3):
A su-BBN (2,1 .55 g, 5.00 mmol, 1equiv) was dissolved in anhydrous CH 2 Cl 2 /THF (1:1, 100 mL) under nitrogen. After addition of pyridine (0.40 mL, 5.00 mmol, 1equiv) and thionyl chloride (0.36 mL, 5.00 mmol, 1equiv) the reaction mixture was stirred at room temperature for 1h,r esulting in the acid chloride of 2.
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In parallel, N-Boc-1,2-phenylenediamine (1.08 g, 5.19 mmol, 1.03 equiv) was dissolved in anhydrous CH 2 Cl 2 (20 mL) under nitrogen, N,O-bis(trimethylsilyl)acetamide (2.43 mL, 10.0 mmol, 2equiv) was added, and the mixture was heated under reflux for 1h.T he mixture was allowed to cool down to room temperature, followed by addition of DIPEA (3.48 mL, 20.0 mmol, 4equiv).
The solution was added dropwise to the previously prepared acid chloride of 2.T he mixture was stirred overnight at room temperature and then concentrated under reduced pressure to yield crude product 3 as ar eddish brown oil, which was used in the next step without further purification.
H-AsuApa(Boc)-OH (4):C rude AsuApa(Boc)-BBN (3,c orresponding to 5.00 mmol of 2)w as dissolved in THF (20 mL), ethylenediamine (3.34 mL, 50.0 mmol, 10 equiv) was added, and the mixture was heated for 1min below the boiling point. Further ethylenediamine (3.34 mL, 50.0 mmol, 10 equiv) was added and the heating procedure was repeated. The solvent was removed under reduced pressure and the residue was dissolved in MeCN/H 2 O. The pH was adjusted to 6w ith TFAa nd the crude product was purified by preparative HPLC, resulting in 4,w hich was obtained as ar ed powder (403 mg, 1.06 mmol, 21 %with respect to 2).
Fmoc-AsuApa(Boc)-OH (5):H -AsuApa(Boc)-OH (4,4 03 mg, 1.06 mmol, 1equiv) and NaHCO 3 (403 mg, 1.06 mmol, 1equiv) were dissolved in dioxane/H 2 O( 1:1, 40 mL), and Fmoc-OSu (371 mg, 1.10 mmol, 1.04 equiv) was added. The reaction mixture was stirred for 3h at room temperature, concentrated under reduced pressure, and lyophilized. The reddish crude product was purified by flash chromatography with silica gel as stationary and MeOH/CH 2 Cl 2 (1:19, v/v)a sm obile phase. The desired product 5 was obtained as ac olorless solid (375 mg, 0.62 mmol, 13 %w ith respect to 1).
Other experimental procedures, including general methods, SPPS, pull-down assays, chemical proteomics, and data processing, can be found in the Supporting Information.
